2019
DOI: 10.1111/bjh.16221
|View full text |Cite
|
Sign up to set email alerts
|

UK guidelines on the management of iron deficiency in pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
498
3
58

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 309 publications
(565 citation statements)
references
References 86 publications
(95 reference statements)
6
498
3
58
Order By: Relevance
“…It is hoped that as clinicians get more comfortable with managing anaemic women for short periods of time while their haemoglobin increases, the transfusion thresholds may improve. 10 The results of our intervention are less dependent on education than the antenatal haemoglobin optimisation interventions.…”
Section: Lessons and Limitationsmentioning
confidence: 92%
See 2 more Smart Citations
“…It is hoped that as clinicians get more comfortable with managing anaemic women for short periods of time while their haemoglobin increases, the transfusion thresholds may improve. 10 The results of our intervention are less dependent on education than the antenatal haemoglobin optimisation interventions.…”
Section: Lessons and Limitationsmentioning
confidence: 92%
“…However, obstetric management guidelines recommend screening pregnant women for anaemia with a FBC only and do not suggest universal screening with ferritin or universal iron replacement in high income countries. [10][11][12] This is despite prior work demonstrating the potential to reduce transfusion with antepartum identification and management of iron deficiency. 16 The prevalence of iron depletion is high in young women and pregnancy, particularly during the third trimester when there is an additional strain on iron stores.…”
Section: Lessons and Limitationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Whereas prospective outcome data on iron supplementation are lacking, given the very high safety profile of medicinal iron, irrespective of the route of administration, one could posit erring on the side of repletion and screening would be more prudent. Supporting this recommendation is a recently published study, referenced in the manuscript which is the subject of this editorial (Pavord et al , ), of 104 consecutive, non‐selected, non‐anaemic, first trimester gravidas who were screened for iron deficiency with tests for serum ferritin and percent transferrin saturation (Auerbach et al , ). Based on either serum ferritin or transferrin saturation, 42% were deficient, suggesting that the recommendations of the USPSTF should be revisited, moving towards a more aggressive paradigm of screening and treatment, to mitigate statistically significant negative outcomes in infants born with iron deficiency.…”
mentioning
confidence: 99%
“…The mechanisms of IDA differ between developed and underdeveloped countries and between the groups at risk in developed countries. More details on these aspects are available elsewhere . IDA can be determined by standard laboratory testing and the extent of the iron deficit measured using the Ganzoni formula (iron deficit [mg] = patient weight (kg) × (target – actual hemoglobin [Hb]) × 2.4 + 500) or a derivative of this formula .…”
mentioning
confidence: 99%